Materials Transfer Agreement Clause Samples

A Materials Transfer Agreement (MTA) is a legal contract that governs the transfer of tangible research materials between two organizations or individuals. It typically outlines the rights and obligations of both the provider and recipient regarding the use, handling, and ownership of the materials, such as biological samples, chemical compounds, or proprietary reagents. By clearly defining permitted uses, restrictions, and intellectual property considerations, the MTA ensures that both parties understand their responsibilities and helps prevent disputes over misuse or unauthorized distribution of the materials.
Materials Transfer Agreement. The Company shall deliver the “Materials” (as defined in the MTA) to the Parent in accordance with the MTA, which the Parent may use solely in accordance with applicable Law and subject to the terms set forth in the MTA.
View SourceView Similar (3)
Materials Transfer Agreement. Any 3DP Compounds which do ---------------------------- not meet the criteria for Lead Compounds, but which are identified by the Research Committee for further study to develop structure-activity relationships may, with 3DP's consent, be transferred to BIOCRYST for further study. Such transferred 3DP Compounds will be transferred and tested pursuant to the Materials Transfer Agreement in the form of Exhibit F hereto and executed by the parties herewith. Compounds contained in BioCryst Libraries which do not meet the criteria for Lead Compounds, but which are identified by the Research Committee for screening or for further study to develop structure-activity relationships may, with BioCryst's consent, be transferred from BIOCRYST to 3DP for further study. Such transferred compounds will be transferred and tested pursuant to the Materials Transfer Agreement in the form of Exhibit G hereto and executed by the parties herewith.
View SourceView Similar (2)
Materials Transfer Agreement. Promptly after the execution of this Agreement, the parties will prepare and execute a materials transfer agreement, with commercially reasonable terms, whereby, until the expiration of all patent license agreements contemplated by this Agreement, Chrysalis will agree to provide TP508 or related peptides for preclinical studies (GLP or equivalent, lot verified) in 1 milligram vials (not sterile) for $150 per milligram or in 5 milligram vials (not sterilized) for $80 per milligram ($400 per vial). During the term of any patent license agreement contemplated by this Agreement, Chrysalis will also supply TP508 or related peptides for end-product manufacture and commercial use, as follows: Small quantity vials (up to 3 micrograms per vial), sterile, delivered, $15.00 each; and 5-10 gram bulk, non-sterile, delivered $3.00 per microgram.
View Source
Materials Transfer Agreement. Pursuant to the Option Agreement to which this Materials Transfer Agreement is attached (hereinafter, the “Option Agreement”), WSU may provide COMPANY with tangible research materials relating to the Patent Rights. In the event of any such transfer of materials, COMPANY agrees as follows:
View Source
Materials Transfer Agreement. For distribution to third-party parties of any material developed under this Agreement, the Recipient must provide OTAO and OTTR a Materials Transfer Agreement (MTA). Following finalization of the MTA, the Recipient must provide notice of the requests/transfers in the monthly technical report along with copies of the final MTA.
View Source

Related to Materials Transfer Agreement

  • Transfer Agreement Exhibit B, Transfer Agreement, between the Bureau, CONTRACTOR, and the Florida Department of Corrections (the FDC) which establishes guidelines for transfer of inmates between the Bay Correctional Facility and facilities operated by the FDC.

  • Cooperation Agreement At the Closing, PCC and Buyer shall, and PCC shall cause PCC Parent to, execute and deliver the Cooperation Agreement pursuant to which Buyer, PCC Parent and PCC shall provide each other certain information and other assistance in connection with the collection, administration and/or satisfaction of certain of the Retained Liabilities.

  • Acquisition Agreements If the Equipment is subject to any Acquisition Agreement, Lessee, as part of this lease, transfers and assigns to Lessor all of its rights, but none of its obligations (except for Lessee's obligation to pay for the Equipment conditioned upon Lessee's acceptance in accordance with Paragraph 6), in and to the Acquisition Agreement, including but not limited to the right to take title to the Equipment. Lessee shall indemnify and hold Lessor harmless in accordance with Paragraph 19 from any liability resulting from any Acquisition Agreement as well as liabilities resulting from any Acquisition Agreement Lessor is required to enter into on behalf of Lessee or with Lessee for purposes of this lease.

  • Development Agreement As soon as reasonably practicable following the ISO’s selection of a transmission Short-Term Reliability Process Solution, the ISO shall tender to the Developer that proposed the selected transmission Short-Term Reliability Process Solution a draft Development Agreement, with draft appendices completed by the ISO to the extent practicable, for review and completion by the Developer. The draft Development Agreement shall be in the form of the ISO’s Commission-approved Development Agreement for its Reliability Planning Process, which is in Appendix C in Section 31.7 of Attachment Y of the ISO OATT, as amended by the ISO to reflect the Short-Term Reliability Process. The ISO and the Developer shall finalize the Development Agreement and appendices as soon as reasonably practicable after the ISO’s tendering of the draft Development Agreement. For purposes of finalizing the Development Agreement, the ISO and Developer shall develop the description and dates for the milestones necessary to develop and construct the selected project by the required in-service date identified in the STAR or Generator Deactivation Assessment, including the milestones for obtaining all necessary authorizations. Any milestone that requires action by a Connecting Transmission Owner or Affected System Operator identified pursuant to Attachment P of the ISO OATT to complete must be included as an Advisory Milestone, as that term is defined in the Development Agreement. If the ISO or the Developer determines that negotiations are at an impasse, the ISO may file the Development Agreement in unexecuted form with the Commission on its own, or following the Developer’s request in writing that the agreement be filed unexecuted. If the Development Agreement is executed by both parties, the ISO shall file the agreement with the Commission for its acceptance within ten (10) Business Days after the execution of the Development Agreement by both parties. If the Developer requests that the Development Agreement be filed unexecuted, the ISO shall file the agreement at the Commission within ten (10) Business Days of receipt of the request from the Developer. The ISO will draft, to the extent practicable, the portions of the Development Agreement and appendices that are in dispute and will provide an explanation to the Commission of any matters as to which the parties disagree. The Developer will provide in a separate filing any comments that it has on the unexecuted agreement, including any alternative positions it may have with respect to the disputed provisions. Upon the ISO’s and the Developer’s execution of the Development Agreement or the ISO’s filing of an unexecuted Development Agreement with the Commission, the ISO and the Developer shall perform their respective obligations in accordance with the terms of the Development Agreement that are not in dispute, subject to modification by the Commission. The Connecting Transmission Owner(s) and Affected System Operator(s) that are identified in Attachment P of the ISO OATT in connection with the selected transmission Short-Term Reliability Process Solution shall act in good faith in timely performing their obligations that are required for the Developer to satisfy its obligations under the Development Agreement.

  • Amendment to Purchase Agreement Section 1.3 of the Purchase Agreement is hereby amended and restated in its entirety to read as follows: